Moreover, it was found that transforming growth factor β (TGFβ), the most potent profibrotic molecule that is crucially involved in the pathophysiology of SSc, downregulates Dkk-1 expression [20]. The gene discussed is TGFB1; the disease is systemic sclerosis.